Almotriptan 12.5 MG Oral Tablet — RxCUI 284205
RxNorm drug concept · Semantic clinical drug
RxCUI 284205
Semantic clinical drug · SCD
● Current RxNorm concept 6 FDA products
6 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI284205
Official nameAlmotriptan 12.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asalmotriptan malate 12.5 MG Oral Tablet
FDA products mapped6
Package NDCs mapped6
Reported Medicaid activity (SDUD)2,385 prescriptions · 22 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Almotriptan: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- No, almotriptan is not a regular painkiller like ibuprofen or acetaminophen. It's a specific migraine medicine called a triptan. It works by targeting the serotonin receptors invol...
- What exactly is almotriptan for — is it the same as a regular painkiller?
- It's best to take almotriptan as soon as you recognize a migraine is starting — you don't need to wait for the pain to peak. Taking it early generally gives the best results. If th...
- When should I take it — do I wait until the headache is really bad?
🕸️ Concept Web — How Almotriptan 12.5 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Almotriptan 12.5 MG Oral Tablet
RxCUI 284205 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Almotriptan
279645IN
-
Almotriptan
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Almotriptan Oral Tablet
374657SCDF -
Almotriptan Oral Product
1164908SCDG -
Almotriptan Pill
1164909SCDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Almotriptan Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Almotriptan 12.5 MG
332453SCDC
-
Almotriptan 12.5 MG
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Almotriptan 12.5 MG
SCDC · 332453 -
Almotriptan Oral Tablet
SCDF · 374657 -
Almotriptan Oral Product
SCDG · 1164908 -
Almotriptan Pill
SCDG · 1164909
📦 FDA Products & Package NDCs
6 products · 6 package NDCs
6 package NDCs map to RxCUI 284205 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00093-5260-18 | 6 BLISTER PACK in 1 CARTON (0093-5260-18) / 1 TABLET, FILM... | Almotriptan Malate | Teva Pharmaceuticals USA, Inc. | 2015-07-07 |
| 00093-5261-29 | 12 BLISTER PACK in 1 CARTON (0093-5261-29) / 1 TABLET, FILM... | Almotriptan Malate | Teva Pharmaceuticals USA, Inc. | 2015-07-07 |
| 00378-5245-85 | 1 BLISTER PACK in 1 CARTON (0378-5245-85) / 6 TABLET, FILM... | Almotriptan Malate | Mylan Pharmaceuticals Inc. | 2015-11-10 |
| 00378-5246-85 | 2 BLISTER PACK in 1 CARTON (0378-5246-85) / 6 TABLET, FILM... | Almotriptan Malate | Mylan Pharmaceuticals Inc. | 2015-11-10 |
| 27241-0041-11 | 1 BLISTER PACK in 1 CARTON (27241-041-11) / 6 TABLET, FILM... | almotriptan | Ajanta Pharma USA Inc. | 2015-10-07 |
| 27241-0042-21 | 2 BLISTER PACK in 1 CARTON (27241-042-21) / 6 TABLET, FILM... | almotriptan | Ajanta Pharma USA Inc. | 2015-10-07 |
Observed labelers:
Ajanta Pharma USA Inc. (2) ·
Mylan Pharmaceuticals Inc. (2) ·
Teva Pharmaceuticals USA, Inc. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.